[go: up one dir, main page]

CN110590771A - A kind of [1,5-a]-pyridoimidazole-1-carbonitrile and its chemical synthesis method - Google Patents

A kind of [1,5-a]-pyridoimidazole-1-carbonitrile and its chemical synthesis method Download PDF

Info

Publication number
CN110590771A
CN110590771A CN201910836615.0A CN201910836615A CN110590771A CN 110590771 A CN110590771 A CN 110590771A CN 201910836615 A CN201910836615 A CN 201910836615A CN 110590771 A CN110590771 A CN 110590771A
Authority
CN
China
Prior art keywords
pyridoimidazole
compound
pyridylimidazole
chemical synthesis
carbonitrile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201910836615.0A
Other languages
Chinese (zh)
Other versions
CN110590771B (en
Inventor
汤艳峰
潘锦洋
孙同明
王敏敏
王淼
王金
邹逢霞
张梦珂
刘维群
汪永霞
毛雯菲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nantong University
Original Assignee
Nantong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nantong University filed Critical Nantong University
Priority to CN201910836615.0A priority Critical patent/CN110590771B/en
Publication of CN110590771A publication Critical patent/CN110590771A/en
Application granted granted Critical
Publication of CN110590771B publication Critical patent/CN110590771B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

本发明涉及一种[1,5‑a]‑吡啶并咪唑‑1‑腈的化学合成方法。所述方法为:以2‑氟吡啶为原料出发,经关环、水解、酰卤化、酰胺化和脱水五步反应合成了[1,5‑a]‑吡啶并咪唑‑1‑腈,为该化合物的合成提供了一种高效合成的方法。

The invention relates to a chemical synthesis method of [1,5-a]-pyridoimidazole-1-carbonitrile. The method is as follows: starting from 2-fluoropyridine, [1,5-a]-pyridimidazole-1-carbonitrile is synthesized through five steps of ring closure, hydrolysis, acid halide, amidation and dehydration. The synthesis of compounds provides an efficient synthetic method.

Description

一种[1,5-a]-吡啶并咪唑-1-腈及其化学合成方法A kind of [1,5-a]-pyridoimidazole-1-carbonitrile and its chemical synthesis method

技术领域technical field

本发明涉及一种[1,5-a]-吡啶并咪唑-1-腈及其化学合成方法。The invention relates to [1,5-a]-pyridoimidazole-1-carbonitrile and a chemical synthesis method thereof.

背景技术Background technique

吡啶并咪唑类化合物具有抗病毒、抗细菌、抗微生物活性、抗疲劳和抗焦虑等作用,在治疗肿瘤、高血压、胃溃疡、精神病等药物中也有广泛的应用。咪唑并吡啶类化合物作为精细化工产品中间体,在催化剂、医药、农药、等领域用途广泛。因此,咪唑并吡啶类化合物的合成具有非常重要的意义。Pyridoimidazoles have antiviral, antibacterial, antimicrobial, anti-fatigue and anti-anxiety effects, and are also widely used in the treatment of tumors, hypertension, gastric ulcers, and psychosis. As intermediates of fine chemical products, imidazopyridine compounds are widely used in catalysts, medicines, pesticides, and other fields. Therefore, the synthesis of imidazopyridine compounds is of great significance.

一种[1,5-a]-吡啶并咪唑-1-腈是一种重要的医药中间体,因此对该化合物的合成研究具有重要现实意义。A kind of [1,5-a]-pyridoimidazole-1-carbonitrile is an important pharmaceutical intermediate, so the synthesis research of this compound has important practical significance.

发明内容Contents of the invention

本发明的目的在于,提供一种可作为医药中间体的化合物,即:[1,5-a]-吡啶并咪唑-1-腈,同时提供其化学合成方法。The object of the present invention is to provide a compound that can be used as a pharmaceutical intermediate, namely: [1,5-a]-pyridoimidazole-1-carbonitrile, and provide its chemical synthesis method.

为实现上述目的,本发明的技术方案如下:To achieve the above object, the technical scheme of the present invention is as follows:

一种化合物Ⅰ,即:[1,5-a]-吡啶并咪唑-1-腈,其特征在于,分子结构式如式1所示。A compound I, namely: [1,5-a]-pyridimidazole-1-carbonitrile, is characterized in that its molecular structure is as shown in Formula 1.

所述的化合物Ⅰ的化学合成方法,其特征在于,以2-氟吡啶为原料,经五步反应合成化合物Ⅰ,如式2所示。The chemical synthesis method of the compound I is characterized in that the compound I is synthesized through five-step reactions using 2-fluoropyridine as a raw material, as shown in formula 2.

所述的化合物Ⅰ的化学合成方法,其特征在于,包含如下合成步骤:The chemical synthesis method of the compound I is characterized in that it comprises the following synthesis steps:

S1、在氮气保护下,在二甲基亚砜中加入氢化钠,将温度控制在0℃,加入氰基乙酸乙酯,搅拌0.5h。随后加入2-氟吡啶,控制反应温度,反应12h,得到[1,5-a]-吡啶并咪唑-1-甲酸乙酯;S1. Under the protection of nitrogen, add sodium hydride to dimethyl sulfoxide, control the temperature at 0° C., add ethyl cyanoacetate, and stir for 0.5 h. Then add 2-fluoropyridine, control the reaction temperature, and react for 12 hours to obtain ethyl [1,5-a]-pyridimidazole-1-carboxylate;

S2、将步骤S1得到的[1,5-a]-吡啶并咪唑-1-甲酸乙酯,加入到甲醇中,随后加入无机碱的水溶液,控制反应温度反应3h后,加入盐酸,得到[1,5-a]-吡啶并咪唑-1-甲酸;S2. Add the ethyl [1,5-a]-pyridoimidazole-1-carboxylate obtained in step S1 into methanol, then add an aqueous solution of an inorganic base, control the reaction temperature and react for 3 hours, then add hydrochloric acid to obtain [1 ,5-a]-pyridoimidazole-1-carboxylic acid;

S3、将步骤S2得到的[1,5-a]-吡啶并咪唑-1-甲酸加入到二氯甲烷中,随后加入氯化亚砜,回流3h后,得到[1,5-a]-吡啶并咪唑-1-甲酰氯;S3. Add [1,5-a]-pyridoimidazole-1-carboxylic acid obtained in step S2 into dichloromethane, then add thionyl chloride, and reflux for 3 hours to obtain [1,5-a]-pyridine And imidazole-1-carbonyl chloride;

S4、将氨水控制到一定温度,随后加入步骤S3得到的[1,5-a]-吡啶并咪唑-1-甲酰氯,搅拌反应3h,得到[1,5-a]-吡啶并咪唑-1-甲酰胺;S4. Control the ammonia water to a certain temperature, then add the [1,5-a]-pyridoimidazole-1-carbonyl chloride obtained in step S3, and stir for 3 hours to obtain [1,5-a]-pyridoimidazole-1 - Formamide;

S5、将步骤S4得到的[1,5-a]-吡啶并咪唑-1-甲酰胺加入到三氯氧磷中,在一定温度下反应2h,反应得到[1,5-a]-吡啶并咪唑-1-腈。S5. Add the [1,5-a]-pyridoimidazole-1-carboxamide obtained in step S4 into phosphorus oxychloride, and react at a certain temperature for 2 hours to obtain [1,5-a]-pyrido imidazole-1-carbonitrile.

进一步的,所述步骤S1的反应温度为30-70℃。Further, the reaction temperature of the step S1 is 30-70°C.

进一步的,所述步骤S2的反应温度为30-100℃,无机碱为氢氧化钠、碳酸钾、氢氧化钾中的一种。Further, the reaction temperature in step S2 is 30-100° C., and the inorganic base is one of sodium hydroxide, potassium carbonate, and potassium hydroxide.

进一步的,所述步骤S4的一定温度为-10-20℃。Further, the certain temperature in the step S4 is -10-20°C.

进一步的,所述步骤S5的一定温度为50-110℃。Further, the certain temperature in the step S5 is 50-110°C.

本发明的有益效果在于:本发明的化学合成方法,以2-氟吡啶为原料,经五步反应合成了[1,5-a]-吡啶并咪唑-1-腈。本发明方法简单,成本低,为该类化合物材料的大量生产和后续研究提供坚实的基础。The beneficial effect of the present invention is that: the chemical synthesis method of the present invention uses 2-fluoropyridine as a raw material to synthesize [1,5-a]-pyridimidazole-1-carbonitrile through five-step reactions. The method of the invention is simple and low in cost, and provides a solid foundation for mass production and follow-up research of this type of compound material.

附图说明Description of drawings

图1为实施例1制备的化合物Ⅰ的1H-NMR谱图。Figure 1 is the 1H-NMR spectrum of compound I prepared in Example 1.

具体实施方法Specific implementation method

下面具体实施方式,对本发明的具体实施方案做详细的阐述。这些具体实施方式仅供叙述并非用来限定本发明的范围或实施原则,本发明的保护范围以权利要求为准,包括在此基础上所作出的显而易见的变化或变动等。The specific implementation mode below will describe in detail the specific implementation of the present invention. These specific implementation methods are only for description and are not used to limit the scope or implementation principle of the present invention. The protection scope of the present invention shall be determined by the claims, including obvious changes or changes made on this basis.

实施例1Example 1

S1、[1,5-a]-吡啶并咪唑-1-甲酸乙酯的合成:Synthesis of S1, [1,5-a]-pyridoimidazole-1-carboxylic acid ethyl ester:

96g钠氢加入到5L的四口烧瓶中,机械搅拌下,将体系温度控制在0℃滴加2L的DMSO,滴加完,缓慢滴加271g氰基乙酸乙酯,滴加完搅拌30min,194g 2-氟吡啶也被缓慢滴加到体系中。滴毕,50℃下搅拌反应12h。薄层色谱分析原料反应完全,降温至0℃,滴加100mL水淬灭反应,加入6L水,乙酸乙酯萃取3次(3×2L),无水硫酸钠干燥有机相,浓缩至干,得[1,5-a]-吡啶并咪唑-1-甲酸乙酯131g,收率为35%。Add 96g of sodium hydrogen into a 5L four-neck flask, under mechanical stirring, control the system temperature at 0°C, add 2L of DMSO dropwise, after the dropwise addition, slowly add 271g of ethyl cyanoacetate, and stir for 30min after the dropwise addition, 194g 2-fluoropyridine was also slowly added dropwise into the system. After dropping, the mixture was stirred and reacted at 50°C for 12h. According to thin-layer chromatography, the reaction of the raw materials was complete, cooled to 0°C, and 100 mL of water was added dropwise to quench the reaction, 6 L of water was added, and ethyl acetate extracted 3 times (3×2 L), the organic phase was dried over anhydrous sodium sulfate, and concentrated to dryness to obtain [1,5-a]-Pyridoimidazole-1-carboxylic acid ethyl ester 131g, yield 35%.

S2、[1,5-a]-吡啶并咪唑-1-甲酸的合成:Synthesis of S2, [1,5-a]-pyridoimidazole-1-carboxylic acid:

在1L的四口烧瓶中40g[1,5-a]-吡啶并咪唑-1-甲酸乙酯溶于200mL的12.6g的氢氧化钠溶液中,70℃搅拌3h。薄层色谱分析原料反应完全,冷却至室温,12M盐酸调节pH=3-4,有大量固体析出,过滤,滤饼用水淋洗,烘干,得[1,5-a]-吡啶并咪唑-1-甲酸32.8g,收率为96.2%。In a 1L four-neck flask, 40g of [1,5-a]-pyridoimidazole-1-carboxylic acid ethyl ester was dissolved in 200mL of 12.6g of sodium hydroxide solution, and stirred at 70°C for 3h. According to thin-layer chromatography, the reaction of raw materials was complete, cooled to room temperature, adjusted to pH=3-4 with 12M hydrochloric acid, a large amount of solids precipitated, filtered, rinsed with water, and dried to obtain [1,5-a]-pyridimidazole- 32.8 g of 1-formic acid, the yield is 96.2%.

S3、[1,5-a]-吡啶并咪唑-1-甲酰氯的合成:Synthesis of S3, [1,5-a]-pyridoimidazole-1-carbonyl chloride:

在0.25L的反应瓶中加入120.5g氯化亚砜溶于0.1L乙腈中,磁力搅拌下,分批次加入32.8g[1,5-a]-吡啶并咪唑-1-甲酸,加完加热回流3h。薄层色谱分析原料反应完全,浓缩至干,得到[1,5-a]-吡啶并咪唑-1-甲酰氯,直接进行下一步。Add 120.5g of thionyl chloride to a 0.25L reaction flask and dissolve it in 0.1L of acetonitrile. Under magnetic stirring, add 32.8g of [1,5-a]-pyridoimidazole-1-carboxylic acid in batches, and heat Reflux for 3h. Thin-layer chromatography analyzed that the reaction of raw materials was complete, and concentrated to dryness to obtain [1,5-a]-pyridoimidazole-1-carbonyl chloride, which was directly carried out to the next step.

S4、[1,5-a]-吡啶并咪唑-1-甲酰胺的合成:Synthesis of S4, [1,5-a]-pyridoimidazole-1-carboxamide:

在1L的四颈瓶中加入上一步[1,5-a]-吡啶并咪唑-1-甲酰氯溶于0.2L甲基叔丁基醚中,磁力搅拌下,缓慢将上述酰氯溶液加入到400mL15℃以下的氨水中,加毕,继续搅拌3h。薄层色谱分析原料反应完全,过滤,滤饼水洗,烘干,滤液用二氯甲烷萃取8次(8×200mL),无水硫酸钠干燥,浓缩至干,烘干,总计得27g[1,5-a]-吡啶并咪唑-1-甲酰胺,产率为83.1%。Add the previous step [1,5-a]-pyridoimidazole-1-carbonyl chloride to a 1L four-necked flask and dissolve it in 0.2L methyl tert-butyl ether, and slowly add the above acid chloride solution to 400mL15 After adding ammonia water below ℃, continue to stir for 3h. Thin-layer chromatography analysis raw materials reacted completely, filtered, the filter cake was washed with water, dried, and the filtrate was extracted 8 times with dichloromethane (8 × 200mL), dried over anhydrous sodium sulfate, concentrated to dryness, and dried to obtain a total of 27g[1, 5-a]-pyridoimidazole-1-carboxamide, the yield was 83.1%.

S5、[1,5-a]-吡啶并咪唑-1-腈的合成:Synthesis of S5, [1,5-a]-pyridoimidazole-1-carbonitrile:

在100mL的三颈瓶中加入24g[1,5-a]-吡啶并咪唑-1-甲酰胺,加入25mL三氯氧磷,110℃下反应2h。薄层色谱分析原料反应完全,浓缩完三氯氧磷,剩余物加入到冰水中,加入乙酸乙酯500mL,搅拌0.5h,垫硅胶过滤,滤饼乙酸乙酯淋洗,分液,有机相干燥,浓缩,甲基叔丁基醚打浆,得到18g[1,5-a]-吡啶并咪唑-1-腈,其1H-NMR谱图如图1所示。产率为84.5%。Add 24g of [1,5-a]-pyridoimidazole-1-carboxamide into a 100mL three-necked flask, add 25mL of phosphorus oxychloride, and react at 110°C for 2h. According to thin-layer chromatography, the reaction of the raw materials was complete, the phosphorus oxychloride was concentrated, the residue was added to ice water, 500 mL of ethyl acetate was added, stirred for 0.5 h, filtered with a pad of silica gel, the filter cake was rinsed with ethyl acetate, separated, and the organic phase was dried , concentrated, and slurried with methyl tert-butyl ether to obtain 18g of [1,5-a]-pyridoimidazole-1-carbonitrile, the 1H-NMR spectrum of which is shown in Figure 1. The yield was 84.5%.

实施例2Example 2

S1、[1,5-a]-吡啶并咪唑-1-甲酸乙酯的合成:Synthesis of S1, [1,5-a]-pyridoimidazole-1-carboxylic acid ethyl ester:

96g钠氢加入在5L的四口烧瓶中,机械搅拌下,将体系温度控制在0℃滴加2L的DMSO,滴加完,缓慢滴加271g氰基乙酸乙酯,滴加完搅拌30min,194g 2-氟吡啶也被缓慢滴加到体系中。滴毕,30℃下搅拌反应12h。薄层色谱分析原料反应完全,降温至0℃,滴加100mL水淬灭反应,加入6L水,乙酸乙酯萃取3次(3×2L),无水硫酸钠干燥有机相,浓缩至干,得[1,5-a]-吡啶并咪唑-1-甲酸乙酯123g,收率为32.9%。Add 96g of sodium hydrogen into a 5L four-neck flask, under mechanical stirring, control the temperature of the system at 0°C, add 2L of DMSO dropwise, after the dropwise addition, slowly add 271g of ethyl cyanoacetate dropwise, after the dropwise addition, stir for 30min, 194g 2-fluoropyridine was also slowly added dropwise into the system. After dropping, the mixture was stirred and reacted at 30°C for 12h. According to thin-layer chromatography, the reaction of raw materials was complete, cooled to 0°C, 100 mL of water was added dropwise to quench the reaction, 6 L of water was added, ethyl acetate extracted 3 times (3×2 L), the organic phase was dried over anhydrous sodium sulfate, and concentrated to dryness to obtain 123 g of ethyl [1,5-a]-pyridoimidazole-1-carboxylate, the yield was 32.9%.

S2、[1,5-a]-吡啶并咪唑-1-甲酸的合成:Synthesis of S2, [1,5-a]-pyridoimidazole-1-carboxylic acid:

在1L的四口烧瓶中40g[1,5-a]-吡啶并咪唑-1-甲酸乙酯溶于200mL的12.6g的氢氧化钠溶液中,50℃搅拌3h。薄层色谱分析原料反应完全,冷却至室温,12M盐酸调节pH=3-4,有大量固体析出,过滤,滤饼用水淋洗,烘干,得[1,5-a]-吡啶并咪唑-1-甲酸32.0g,收率为93.9%。In a 1L four-necked flask, 40g of [1,5-a]-pyridoimidazole-1-carboxylic acid ethyl ester was dissolved in 200mL of 12.6g of sodium hydroxide solution, and stirred at 50°C for 3h. According to thin-layer chromatography, the reaction of raw materials was complete, cooled to room temperature, adjusted to pH=3-4 with 12M hydrochloric acid, a large amount of solids precipitated, filtered, rinsed with water, and dried to obtain [1,5-a]-pyridimidazole- 32.0 g of 1-formic acid, the yield is 93.9%.

S3、[1,5-a]-吡啶并咪唑-1-甲酰氯的合成:Synthesis of S3, [1,5-a]-pyridoimidazole-1-carbonyl chloride:

在0.25L的反应瓶中加入120.5g氯化亚砜溶于0.1L乙腈中,磁力搅拌下,分批次加入32.8g[1,5-a]-吡啶并咪唑-1-甲酸,加完加热回流3h。薄层色谱分析原料反应完全,浓缩至干,得到[1,5-a]-吡啶并咪唑-1-甲酰氯,直接进行下一步。Add 120.5g of thionyl chloride to a 0.25L reaction flask and dissolve it in 0.1L of acetonitrile. Under magnetic stirring, add 32.8g of [1,5-a]-pyridoimidazole-1-carboxylic acid in batches, and heat Reflux for 3h. Thin-layer chromatography analyzed that the reaction of raw materials was complete, and concentrated to dryness to obtain [1,5-a]-pyridoimidazole-1-carbonyl chloride, which was directly carried out to the next step.

S4、[1,5-a]-吡啶并咪唑-1-甲酰胺的合成:Synthesis of S4, [1,5-a]-pyridoimidazole-1-carboxamide:

在1L的四颈瓶中加入上一步[1,5-a]-吡啶并咪唑-1-甲酰氯溶于0.2L甲基叔丁基醚中,磁力搅拌下,缓慢将上述酰氯溶液加入到400mL-10℃以下的氨水中,加毕,继续搅拌3h。薄层色谱分析原料反应完全,过滤,滤饼水洗,烘干,滤液用二氯甲烷萃取8次(8×200mL),无水硫酸钠干燥,浓缩至干,烘干,总计得21g[1,5-a]-吡啶并咪唑-1-甲酰胺,产率为64.6%。Add the previous step [1,5-a]-pyridoimidazole-1-carbonyl chloride to a 1L four-neck flask and dissolve it in 0.2L methyl tert-butyl ether, and slowly add the above acid chloride solution to 400mL under magnetic stirring After adding ammonia water below -10°C, continue stirring for 3 hours. Thin-layer chromatography analysis raw materials reacted completely, filtered, washed the filter cake with water, dried, and the filtrate was extracted 8 times with dichloromethane (8 × 200mL), dried over anhydrous sodium sulfate, concentrated to dryness, and dried to obtain a total of 21g[1, 5-a]-pyridoimidazole-1-carboxamide, the yield was 64.6%.

S5、[1,5-a]-吡啶并咪唑-1-腈的合成:Synthesis of S5, [1,5-a]-pyridoimidazole-1-carbonitrile:

在100mL的三颈瓶中加入24g[1,5-a]-吡啶并咪唑-1-甲酰胺,加入25mL三氯氧磷,80℃下反应2h。薄层色谱分析原料反应完全,浓缩完三氯氧磷,剩余物加入到冰水中,加入乙酸乙酯500mL,搅拌0.5h,垫硅胶过滤,滤饼乙酸乙酯淋洗,分液,有机相干燥,浓缩,甲基叔丁基醚打浆,得到16g[1,5-a]-吡啶并咪唑-1-腈,产率为75.1%。Add 24g of [1,5-a]-pyridoimidazole-1-carboxamide into a 100mL three-necked flask, add 25mL of phosphorus oxychloride, and react at 80°C for 2h. According to thin-layer chromatography, the reaction of the raw materials was complete, the phosphorus oxychloride was concentrated, the residue was added to ice water, 500 mL of ethyl acetate was added, stirred for 0.5 h, filtered with a pad of silica gel, the filter cake was rinsed with ethyl acetate, separated, and the organic phase was dried , concentrated, and beat with methyl tert-butyl ether to obtain 16 g of [1,5-a]-pyridoimidazole-1-carbonitrile with a yield of 75.1%.

实施例3Example 3

S1、[1,5-a]-吡啶并咪唑-1-甲酸乙酯的合成:Synthesis of S1, [1,5-a]-pyridoimidazole-1-carboxylic acid ethyl ester:

96g钠氢加入到5L的四口烧瓶中,机械搅拌下,将体系温度控制在0℃滴加2L的DMSO,滴加完,缓慢滴加271g氰基乙酸乙酯,滴加完搅拌30min,194g 2-氟吡啶也被缓慢滴加到体系中。滴毕,70℃下搅拌反应12h。薄层色谱分析原料反应完全,降温至0℃,滴加100mL水淬灭反应,加入6L水,乙酸乙酯萃取3次(3×2L),无水硫酸钠干燥有机相,浓缩至干,得[1,5-a]-吡啶并咪唑-1-甲酸乙酯133g,收率为35.5%。Add 96g of sodium hydrogen into a 5L four-neck flask, under mechanical stirring, control the system temperature at 0°C, add 2L of DMSO dropwise, after the dropwise addition, slowly add 271g of ethyl cyanoacetate, and stir for 30min after the dropwise addition, 194g 2-fluoropyridine was also slowly added dropwise into the system. After dropping, the mixture was stirred and reacted at 70°C for 12h. According to thin-layer chromatography, the reaction of the raw materials was complete, cooled to 0°C, and 100 mL of water was added dropwise to quench the reaction, 6 L of water was added, and ethyl acetate extracted 3 times (3×2 L), the organic phase was dried over anhydrous sodium sulfate, and concentrated to dryness to obtain [1,5-a]-Pyridoimidazole-1-carboxylic acid ethyl ester 133g, yield 35.5%.

S2、[1,5-a]-吡啶并咪唑-1-甲酸的合成:Synthesis of S2, [1,5-a]-pyridoimidazole-1-carboxylic acid:

在1L的四口烧瓶中40g[1,5-a]-吡啶并咪唑-1-甲酸乙酯溶于200mL的12.6g的氢氧化钠溶液中,100℃搅拌3h。薄层色谱分析原料反应完全,冷却至室温,12M盐酸调节pH=3-4,有大量固体析出,过滤,滤饼用水淋洗,烘干,得[1,5-a]-吡啶并咪唑-1-甲酸33.2g,收率为97.4%。In a 1L four-neck flask, 40g of [1,5-a]-pyridoimidazole-1-carboxylic acid ethyl ester was dissolved in 200mL of 12.6g of sodium hydroxide solution, and stirred at 100°C for 3h. According to thin-layer chromatography, the reaction of raw materials was complete, cooled to room temperature, adjusted to pH=3-4 with 12M hydrochloric acid, a large amount of solids precipitated, filtered, rinsed with water, and dried to obtain [1,5-a]-pyridimidazole- 33.2 g of 1-formic acid, the yield was 97.4%.

S3、[1,5-a]-吡啶并咪唑-1-甲酰氯的合成:Synthesis of S3, [1,5-a]-pyridoimidazole-1-carbonyl chloride:

在0.25L的反应瓶中加入120.5g氯化亚砜溶于0.1L乙腈中,磁力搅拌下,分批次加入32.8g[1,5-a]-吡啶并咪唑-1-甲酸,加完加热回流3h。薄层色谱分析原料反应完全,浓缩至干,得到[1,5-a]-吡啶并咪唑-1-甲酰氯,直接进行下一步。Add 120.5g of thionyl chloride to a 0.25L reaction flask and dissolve it in 0.1L of acetonitrile. Under magnetic stirring, add 32.8g of [1,5-a]-pyridoimidazole-1-carboxylic acid in batches, and heat Reflux for 3h. Thin-layer chromatography analyzed that the reaction of raw materials was complete, and concentrated to dryness to obtain [1,5-a]-pyridoimidazole-1-carbonyl chloride, which was directly carried out to the next step.

S4、[1,5-a]-吡啶并咪唑-1-甲酰胺的合成:Synthesis of S4, [1,5-a]-pyridoimidazole-1-carboxamide:

在1L的四颈瓶中加入上一步[1,5-a]-吡啶并咪唑-1-甲酰氯溶于0.2L甲基叔丁基醚中,磁力搅拌下,缓慢将上述酰氯溶液加入到400mL5℃以下的氨水中,加毕,继续搅拌3h。薄层色谱分析原料反应完全,过滤,滤饼水洗,烘干,滤液用二氯甲烷萃取8次(8×200mL),无水硫酸钠干燥,浓缩至干,烘干,总计得30g[1,5-a]-吡啶并咪唑-1-甲酰胺,产率为92.1%。Add the previous step [1,5-a]-pyridoimidazole-1-carbonyl chloride to a 1L four-necked flask and dissolve it in 0.2L methyl tert-butyl ether, and slowly add the above acid chloride solution to 400mL5 under magnetic stirring. After adding ammonia water below ℃, continue to stir for 3h. Thin-layer chromatography analysis raw materials reacted completely, filtered, washed the filter cake with water, dried, and the filtrate was extracted 8 times with dichloromethane (8 × 200mL), dried over anhydrous sodium sulfate, concentrated to dryness, and dried to obtain a total of 30g[1, 5-a]-Pyridoimidazole-1-carboxamide, the yield is 92.1%.

S5、[1,5-a]-吡啶并咪唑-1-腈的合成:Synthesis of S5, [1,5-a]-pyridoimidazole-1-carbonitrile:

在100mL的三颈瓶中加入24g[1,5-a]-吡啶并咪唑-1-甲酰胺,加入25mL三氯氧磷,50℃下反应2h。薄层色谱分析原料反应完全,浓缩完三氯氧磷,剩余物加入到冰水中,加入乙酸乙酯500mL,搅拌0.5h,垫硅胶过滤,滤饼乙酸乙酯淋洗,分液,有机相干燥,浓缩,甲基叔丁基醚打浆,得到13g[1,5-a]-吡啶并咪唑-1-腈,产率为61%。Add 24g of [1,5-a]-pyridoimidazole-1-carboxamide into a 100mL three-necked flask, add 25mL of phosphorus oxychloride, and react at 50°C for 2h. According to thin-layer chromatography, the reaction of the raw materials was complete, the phosphorus oxychloride was concentrated, the residue was added to ice water, 500 mL of ethyl acetate was added, stirred for 0.5 h, filtered with a pad of silica gel, the filter cake was rinsed with ethyl acetate, separated, and the organic phase was dried , concentrated, and beat with methyl tert-butyl ether to obtain 13 g of [1,5-a]-pyridoimidazole-1-carbonitrile with a yield of 61%.

Claims (7)

1. A compound I, namely: [1,5-a ] -pyridylimidazole-1-carbonitrile, which is characterized in that the molecular structural formula is shown as formula 1.
2. The chemical synthesis method of the compound I as claimed in claim 1, wherein 2-fluoropyridine is used as a raw material to synthesize the compound I through five-step reaction, as shown in formula 2.
3. The chemical synthesis process of compound i according to claim 2, comprising the following synthesis steps:
s1, under the protection of nitrogen, adding sodium hydride into dimethyl sulfoxide, controlling the temperature at 0 ℃, adding ethyl cyanoacetate, and stirring for 0.5 h. Then adding 2-fluoropyridine, controlling the reaction temperature, and reacting for 12h to obtain [1,5-a ] -pyridylimidazole-1-ethyl formate;
s2, adding the [1,5-a ] -pyridoimidazole-1-ethyl formate obtained in the step S1 into methanol, then adding an aqueous solution of an inorganic base, controlling the reaction temperature to react for 3 hours, and then adding hydrochloric acid to obtain [1,5-a ] -pyridoimidazole-1-formic acid;
s3, adding the [1,5-a ] -pyridylimidazole-1-formic acid obtained in the step S2 into dichloromethane, then adding thionyl chloride, and refluxing for 3 hours to obtain [1,5-a ] -pyridylimidazole-1-formyl chloride;
s4, controlling ammonia water to a certain temperature, adding the [1,5-a ] -pyridylimidazole-1-formyl chloride obtained in the step S3, and reacting for 3 hours under stirring to obtain [1,5-a ] -pyridylimidazole-1-formamide;
s5, adding the [1,5-a ] -pyridylimidazole-1-formamide obtained in the step S4 into phosphorus oxychloride, reacting for 2 hours at a certain temperature, and reacting to obtain [1,5-a ] -pyridylimidazole-1-carbonitrile.
4. A process for the chemical synthesis of compound i according to claim 3, characterized in that: the reaction temperature of the step S1 is 30-70 ℃.
5. A process for the chemical synthesis of compound i according to claim 3, characterized in that: the reaction temperature of the step S2 is 30-100 ℃, and the inorganic base is one of sodium hydroxide, potassium carbonate and potassium hydroxide.
6. A process for the chemical synthesis of compound i according to claim 3, characterized in that: the certain temperature of the step S4 is-10-20 ℃.
7. A process for the chemical synthesis of compound i according to claim 3, characterized in that: the certain temperature of the step S5 is 50-110 ℃.
CN201910836615.0A 2019-09-05 2019-09-05 [1,5-a ] -pyridylimidazole-1-nitrile and chemical synthesis method thereof Active CN110590771B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910836615.0A CN110590771B (en) 2019-09-05 2019-09-05 [1,5-a ] -pyridylimidazole-1-nitrile and chemical synthesis method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910836615.0A CN110590771B (en) 2019-09-05 2019-09-05 [1,5-a ] -pyridylimidazole-1-nitrile and chemical synthesis method thereof

Publications (2)

Publication Number Publication Date
CN110590771A true CN110590771A (en) 2019-12-20
CN110590771B CN110590771B (en) 2021-11-12

Family

ID=68857681

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910836615.0A Active CN110590771B (en) 2019-09-05 2019-09-05 [1,5-a ] -pyridylimidazole-1-nitrile and chemical synthesis method thereof

Country Status (1)

Country Link
CN (1) CN110590771B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111233770A (en) * 2020-02-28 2020-06-05 南通大学 A kind of chiral pyrazole derivative and synthetic method thereof

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN87104648A (en) * 1986-07-08 1988-04-13 合成实验室公司 Nitrofuran derivatives and their preparation and use in therapy
CN103864786A (en) * 2014-03-13 2014-06-18 定陶县友帮化工有限公司 Method for synthesizing 6-fluoroimidazo-[1,2-a]-pyridine-3-formic acid
CN103965190A (en) * 2014-05-20 2014-08-06 定陶县友帮化工有限公司 Synthesis method of imidazo[1,2-alpha]pyridyl-3-formic acid
CN106632320A (en) * 2016-11-23 2017-05-10 山东友帮生化科技有限公司 Preparation method of 6-chlorine-imidazo[1,2a]pyridine-3-formamide
CN106632321A (en) * 2016-11-23 2017-05-10 山东友帮生化科技有限公司 Preparation method of 6-bromine-imidazo[1,2a]pyridine-3-formamide
CN109081810A (en) * 2018-09-20 2018-12-25 沈阳药科大学 The synthetic method of 1- methyl-3-((methylamino) methyl)-1H- pyrazoles-5- nitrile
CN110183442A (en) * 2019-06-06 2019-08-30 无锡合全药业有限公司 A kind of synthetic method of 1-(carbethoxyl group) imidazo [1,5] pyridine-6- carboxylic acid

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN87104648A (en) * 1986-07-08 1988-04-13 合成实验室公司 Nitrofuran derivatives and their preparation and use in therapy
CN103864786A (en) * 2014-03-13 2014-06-18 定陶县友帮化工有限公司 Method for synthesizing 6-fluoroimidazo-[1,2-a]-pyridine-3-formic acid
CN103965190A (en) * 2014-05-20 2014-08-06 定陶县友帮化工有限公司 Synthesis method of imidazo[1,2-alpha]pyridyl-3-formic acid
CN106632320A (en) * 2016-11-23 2017-05-10 山东友帮生化科技有限公司 Preparation method of 6-chlorine-imidazo[1,2a]pyridine-3-formamide
CN106632321A (en) * 2016-11-23 2017-05-10 山东友帮生化科技有限公司 Preparation method of 6-bromine-imidazo[1,2a]pyridine-3-formamide
CN109081810A (en) * 2018-09-20 2018-12-25 沈阳药科大学 The synthetic method of 1- methyl-3-((methylamino) methyl)-1H- pyrazoles-5- nitrile
CN110183442A (en) * 2019-06-06 2019-08-30 无锡合全药业有限公司 A kind of synthetic method of 1-(carbethoxyl group) imidazo [1,5] pyridine-6- carboxylic acid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
冯承涛 等: "1-硫氰基咪唑并[1,5-a]吡啶合成工艺研究", 《安徽科技学院学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111233770A (en) * 2020-02-28 2020-06-05 南通大学 A kind of chiral pyrazole derivative and synthetic method thereof
CN111233770B (en) * 2020-02-28 2022-12-27 南通大学 Chiral pyrazole derivative and synthesis method thereof

Also Published As

Publication number Publication date
CN110590771B (en) 2021-11-12

Similar Documents

Publication Publication Date Title
CN106243031B (en) A kind of Ah handkerchief replaces the preparation method of Buddhist nun
CN114805314A (en) Synthesis method of Ensaitevir
CN112062712A (en) Preparation method of 2- (5-bromo-3-methylpyridin-2-yl) acetic acid hydrochloride
CN110669045A (en) 1-methyl- [1,5-a ] -pyridylimidazole-3-nitrile and chemical synthesis method thereof
CN108129513A (en) A kind of method for synthesizing Bouguer and replacing Buddhist nun's intermediate
CN110590771A (en) A kind of [1,5-a]-pyridoimidazole-1-carbonitrile and its chemical synthesis method
CN107118215B (en) A kind of preparation method for treating breast cancer medicines Rui Boxini intermediate
CN105061267A (en) N-hydroxyguanidine NO donor derivatives of bexarotene and preparation method of N-hydroxyguanidine NO donor derivatives
CN106111190A (en) A kind of chirality biaryl skeleton pyridoxamine class catalyst and synthetic method thereof and application
CN117263870A (en) Preparation method of Resmetirom key intermediate III
CN108033892A (en) A kind of preparation method of N- alkyl iminodiacetics acid
CN111848546A (en) A kind of 2-(aminomethyl)thiazole-5-carbonitrile and its synthetic method
CN110590673A (en) A kind of 4-chloro-7-methyl-1H-indazole and its chemical synthesis method
CN115417869B (en) Synthesis method of 6-bromoimidazole [1.2A ] pyridine-3-formamide
CN112898221A (en) Preparation method and intermediate of benzoxazine diketone compound C
CN111499622A (en) Preparation method of medicine for treating bile duct cancer
CN113045475A (en) Preparation method of 5-bromo-7-methylindole
CN117384157B (en) Preparation method and application of camelning B and derivative thereof
CN112679361B (en) Synthetic method of 3-fluoro-5-nitropyridine-2-formaldehyde
EP3026047A1 (en) Method for producing heterocyclic compound
CN103044313A (en) Method for synthesising carbazole compounds
CN111662233B (en) Method for synthesizing 4-chloro-1H-imidazole-2-carboxylic acid ethyl ester by one-step method
CN110194760B (en) Method for preparing 3-benzylidene-2-(7'-quinoline)-2,3-dihydro-isoindol-1-one compounds
CN109053513B (en) Substituted naphthol compound and application thereof in antitumor drugs
CN108033983B (en) Synthetic method of 2- (3,3, 3-trifluoropropyl) thioadenosine

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant